#RARE

Ultragenyx Pharmaceutical Files 8-K Disclosing Asset Disposition and Costs

Ultragenyx Pharmaceutical has filed an 8-K detailing asset disposition, operational results, and exit-related costs, though specific financial terms and guidance remain undisclosed.